Document Detail

New trends in bismuth-catalyzed synthetic transformations.
MedLine Citation:
PMID:  23380745     Owner:  NLM     Status:  Publisher    
This review covers uses of bismuth catalysts since 2005 with a special emphasis on the emerging applications of such catalysts. Low toxicity, low catalytic loading, synergistic effects with other catalysts, and some hydrocompatibility properties confer to bismuth salts major advantages. The expanding activity in the field clearly highlights the growing potential of bismuth catalysts. The article is not a comprehensive review on bismuth catalysis but a selection of its most promising uses in challenging synthetic transformations.
Thierry Ollevier
Related Documents :
24450435 - Safety concerns to application of graphene compounds in pharmacy and medicine.
24752795 - Exogenous sodium nitroprusside and glutathione alleviate copper toxicity by reducing co...
9428975 - N-aralkyl substitution of 2-aminoindans. synthesis and their inotropic and chronotropic...
23806765 - Ten misconceptions about antioxidants.
23215035 - Alpha-heteroatom derivatised analogues of 3-(acetylhydroxyamino)propyl phosphonic acid ...
12398535 - Bioactive constituents from iryanthera megistophylla.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-5
Journal Detail:
Title:  Organic & biomolecular chemistry     Volume:  -     ISSN:  1477-0539     ISO Abbreviation:  Org. Biomol. Chem.     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101154995     Medline TA:  Org Biomol Chem     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Département de chimie, Université Laval, 1045 avenue de la Médecine, Québec (Québec) G1V 0A6, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the...
Next Document:  Unexplained macrocytosis.